CORCEPT THERAPEUTICS INC — Director's Dealing 2011

Jan 13, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2011-01-11

Reporting Person: ROE ROBERT L (President and Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-01-11	Common stock	M	50000	$1.50	Acquired	178890	Direct
2011-01-11	Common stock	S	50000	$4.1352	Disposed	128890	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-01-11	Stock option	$1.50	M	50000	Disposed	2017-04-16	Common stock (50000)	Direct

Footnotes

F1: The sale is made pursuant to terms of a 10b5-1 plan in effect at the time of sale of the shares.

F2: Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $4.00 to $4.28 per share. Full information on the numbers of shares sold at each sale price is available upon request.

F3: Fully exerciseable.